Alert share

Date of changeSharesDirector/
Substantial Shareholder
06 Dec 2022Acquired
115,000
Employees Provident Fund Board
01 Dec 2022Acquired
479,200
Employees Provident Fund Board
30 Nov 2022Acquired
300,000
Employees Provident Fund Board
29 Nov 2022Acquired
538,100
Employees Provident Fund Board
25 Nov 2022Acquired
205,500
Employees Provident Fund Board
25 Nov 2022Acquired
158,600
Yayasan Pelaburan Bumiputra
25 Nov 2022Acquired
158,600
Permodalan Nasional Berhad
24 Nov 2022Acquired
58,200
Employees Provident Fund Board
24 Nov 2022Acquired
1,322,000
Yayasan Pelaburan Bumiputra
24 Nov 2022Acquired
1,322,000
Permodalan Nasional Berhad


Date Title
09 Dec 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
06 Dec 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
05 Dec 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
02 Dec 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
01 Dec 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
30 Nov 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
30 Nov 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
30 Nov 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
29 Nov 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
29 Nov 2022 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD


07 Dec Malaysia healthcare sector in good shape
06 Dec Domestic healthcare sector to see spike in local, foreign patient visits, says RHB Research
16 Nov 【行家论股】联合药业 新药物料末季获批
16 Nov Duopharma Biotech to see improved export revenue ahead, says CGS CIMB Research
16 Nov Duopharma Biotech eyeing a breakout, says RHB Retail Research
11 Nov Affin Bank, Farm Fresh among five added to MSCI Global Small Cap Index, while...
11 Nov Bright outlook for Duopharma despite lower 3Q profit
10 Nov 【行家论股】联合药业 卫生部合约料延长
10 Nov Duopharma’s 9M2022 exceeds expectations but yet to see insulin contract...
10 Nov Duopharma's latest interim results beat expectations, says RHB Research
10 Nov Trading ideas: CapitaLand Malaysia Trust, UEM Edgenta, Duopharma Biotech, Hup Seng Industries, KAB...
10 Nov Duopharma secures higher cumulative profit
10 Nov CLMT, F&N, UEM Edgenta, Duopharma, Hup Seng, Perstima, Kejuruteraan...
09 Nov Duopharma's 3Q net profit down 3.6%, dragged by higher finance and operating...
09 Nov 联合药业第3季净赚1635万


ANNUAL REPORT 2021

ANNUAL REPORT 2020

ANNUAL REPORT 2019

ANNUAL REPORT 2018

ANNUAL REPORT 2018

ANNUAL REPORT 2016

ANNUAL REPORT 2015

ANNUAL REPORT 2014

ANNUAL REPORT 2013

ANNUAL REPORT 2012



Like
ohy72013 and 7 others like this company.
Overview Market Search portfolio More
Overview Market Search Portfolio More
Shariah SettingShariah: Off
Screen ArrangementScreen Arrangement
Recently Viewed